Replay LSI2021 Emerging Medtech Summit

Play Now
innovation hub

Adaptimmune is Profiled in this Database

Updated At 09 Dec, 2009

Start Free 7 Day Trial Now
Partial description of this company
Optimization of T cell receptors (TCRs) for use in adoptive T cell therapy - to target and destroy cancerous/infected cells

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Adaptimmune plus 4917 other startups.

Start Free 7 Day Trial Now

Learn More About Adaptimmune

Technology/product details


Our Clients